anti-PD-1 immunotherapy

Keytruda Adjuvant Therapy Study Shows Reduced the Risk of Disease Recurrence or Death by More Than 40 Percent Compared to Placebo in Stage III Melanoma
CP Wire
Sun, 04/15/18 - 01:54 pm
Merck
Keytruda
melanoma
anti-PD-1 immunotherapy
Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven
Endpoints
Sat, 01/13/18 - 02:01 pm
Genentech
anti-PD-1 immunotherapy
Forty Seven
Recent Developments for Merck’s Keytruda
Market Realist
Fri, 12/1/17 - 12:02 pm
Merck
Keytruda
immuno-oncology
anti-PD-1 immunotherapy
non-small cell lung cancer
Some Immuno-Oncology Drugs Carry Risk of Rare Heart Damage
Xtalks
Mon, 11/7/16 - 09:17 pm
immuno-oncology
heart damage
Opdivo
Yervoy
Bristol-Myers Squibb
anti-PD-1 immunotherapy
Merck's Keytruda extends survival in lung cancer study
Yahoo/Reuters
Mon, 10/26/15 - 04:32 pm
Merck
Keytruda
lung cancer
anti-PD-1 immunotherapy
Former U.S. President Carter gets powerful immune-system boosting drug
Yahoo/Reuters
Fri, 08/21/15 - 08:47 am
Jimmy Carter
melanoma
Merck
Keytruda
anti-PD-1 immunotherapy
Hunting a fast approval in lung cancer, Roche racks up a positive PhII for 'atezo'
Fierce Biotech
Mon, 08/17/15 - 08:10 am
Roche
non-small cell lung cancer
atezolizumab
anti-PD-1 immunotherapy
Merck's Keytruda gains market share in Q2
Medical Marketing and Media
Wed, 07/29/15 - 10:33 am
Merck
Keytruda
anti-PD-1 immunotherapy
Opdivo
Bristol-Myers Squibb
Bristol-Myers takes a big step in its PD-1 lung cancer race with Merck
Fierce Biotech
Mon, 03/2/15 - 12:38 pm
Merck
Bristol-Myers Squibb
lung cancer
anti-PD-1 immunotherapy
Opdivo
Keytruda
Which Cancer Immunotherapy Will Be the Most Successful?
Motley Fool
Sat, 02/28/15 - 12:50 pm
cancer immunotherapy
Opdivo
Bristol-Myers Squibb
Merck
Keytruda
anti-PD-1 immunotherapy
Merck grabs another 'breakthrough' in PD-1 lung cancer race with Bristol-Myers
Fierce Biotech
Mon, 10/27/14 - 09:10 am
Merck
Bristol-Myers Squibb
anti-PD-1 immunotherapy
lung cancer
Keytruda
BMS striving to push Opdivo past Keytruda
Medical Marketing and Media
Wed, 09/17/14 - 09:52 am
Bristol-Myers Squibb
Merck
Opdivo
Keytruda
anti-PD-1 immunotherapy
Merck's Keytruda is shipping
Medical Marketing and Media
Fri, 09/12/14 - 08:48 am
Merck
Keytruda
anti-PD-1 immunotherapy
Will Merck's Anti-PD-1 Therapy be the First to Launch?
Yahoo/Zacks.com
Tue, 07/1/14 - 01:02 pm
Merck
anti-PD-1 immunotherapy
MK-3475
Pharma’s Huge Bet on Immunotherapies
Motley Fool
Wed, 06/25/14 - 07:35 am
immunotherapy
anti-PD-1 immunotherapy
anti-PD-L1
MK-3475
Merck
nivolumab
Roche
Bristol-Myers Squibb
ASCO: Bristol-Myers Squibb and Merck Don't Disappoint
Motley Fool
Thu, 06/5/14 - 11:17 am
ASCO
Merck
Bristol-Myers Squibb
anti-PD-1 immunotherapy
MK-3475
Bristol, Merck, Roche immune therapies are cancer meeting focus
Yahoo/Reuters
Thu, 05/15/14 - 08:24 am
Bristol-Myers Squibb
Merck
Roche
ASCO
cancer
anti-PD-1 immunotherapy
Who's going to win pharma's immunotherapy gold rush?
Fierce Biotech
Tue, 03/25/14 - 08:08 am
immunotherapy
Roche
Bristol-Myers Squibb
Merck
PDL-1
anti-PD-1 immunotherapy
melanoma
Where Is Biotechnology's Next 'Anti-PD-1'?
Seeking Alpha
Tue, 06/18/13 - 09:50 am
anti-PD-1 immunotherapy
Dendreon
Merck
Bristol-Myers Squibb
Baxter International
Yervoy
Provenge
lambrolizumab
MPDL3208A
Important Cancer Therapeutics Under Development To Watch
Seeking Alpha
Tue, 06/5/12 - 09:34 am
cabozantinib
Exelixis
BMS-936558
MDX-1106
cancer
anti-PD-1 immunotherapy
Bristol-Myers Squibb

Pages